- Home
- WSBF vs TARA Comparison
WSBF vs TARA Comparison
Compare WSBF & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSBF | TARA |
|---|---|---|
| Founded | 1921 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.7M | 268.5M |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WSBF | TARA |
|---|---|---|
| Price | $17.24 | $5.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $21.86 |
| AVG Volume (30 Days) | 35.9K | ★ 1.1M |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.44% | N/A |
| EPS Growth | ★ 46.53 | 39.22 |
| EPS | ★ 1.48 | N/A |
| Revenue | N/A | ★ $2,948,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.80 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.61 | $2.77 |
| 52 Week High | $18.88 | $7.82 |
Technical Indicators
Market Signals| Indicator | WSBF | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 41.62 | 44.34 |
| Support Level | $17.22 | $4.87 |
| Resistance Level | $18.63 | $5.77 |
| Average True Range (ATR) | 0.53 | 0.53 |
| MACD | -0.11 | -0.09 |
| Stochastic Oscillator | 27.81 | 20.91 |
Price Performance
Historical ComparisonAbout WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the Community Banking segment.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).